Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Flowers Foods (FLO) Asset Writedowns and Impairment (2016 - 2026)

Flowers Foods (FLO) has disclosed Asset Writedowns and Impairment for 18 consecutive years, with $137.7 million as the latest value for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment rose 11860.55% to $137.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $141.5 million, a 2554.33% increase, with the full-year FY2026 number at $141.5 million, up 6653.03% from a year prior.
  • Asset Writedowns and Impairment was $137.7 million for Q1 2026 at Flowers Foods, up from -$3.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $137.7 million in Q1 2026 to a low of -$21.3 million in Q1 2022.
  • A 5-year average of $8.0 million and a median of $982000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 10545.45% in 2024, then surged 11860.55% in 2026.
  • Flowers Foods' Asset Writedowns and Impairment stood at $3.0 million in 2022, then crashed by 100.36% to -$11000.0 in 2023, then plummeted by 10545.45% to -$1.2 million in 2024, then plummeted by 219.39% to -$3.7 million in 2025, then soared by 3782.25% to $137.7 million in 2026.
  • Per Business Quant, the three most recent readings for FLO's Asset Writedowns and Impairment are $137.7 million (Q1 2026), -$3.7 million (Q4 2025), and $1.4 million (Q3 2025).